Eligibility Criteria

  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Description

Inclusion Criteria

Male or non-pregnant female
Description

Male or non-pregnant female

Data type

boolean

Alias
UMLS CUI-1
C0079399
non-pregnant female
Description

non-pregnant female

Data type

boolean

Alias
UMLS CUI-1
C0549206
at least 18 years of age
Description

at least 18 years of age

Data type

boolean

Alias
UMLS CUI-1
C0001779
Patients undergoing percutaneous coronary intervention (PCI)
Description

Patients undergoing percutaneous coronary intervention (PCI)

Data type

boolean

Alias
UMLS CUI-1
C1532338
Stable angina (SA) patients
Description

Stable angina (SA) patients

Data type

boolean

Alias
UMLS CUI-1
C0002962
with diagnostic coronary angiography
Description

with diagnostic coronary angiography

Data type

boolean

Alias
UMLS CUI-1
C0085532
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Description

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Data type

boolean

Alias
UMLS CUI-1
C3537184
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Description

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Data type

boolean

Alias
UMLS CUI-1
C0948089
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
Description

ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)

Data type

boolean

Alias
UMLS CUI-1
C1536220
Provide written informed consent
Description

Provide written informed consent

Data type

boolean

Alias
UMLS CUI-1
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
Description

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization

Data type

boolean

Alias
UMLS CUI-1
C2936588
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Description

Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Data type

boolean

Alias
UMLS CUI-1
C0253563
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Description

Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Data type

boolean

Alias
UMLS CUI-1
C0247025
Abciximab usage within 7 days preceding randomization
Description

Abciximab usage within 7 days preceding randomization

Data type

boolean

Alias
UMLS CUI-1
C0288672
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
Description

Receipt of fibrinolytic therapy in the 12 hours preceding randomization

Data type

boolean

Alias
UMLS CUI-1
C0040044
Increased bleeding risk
Description

Increased bleeding risk

Data type

boolean

Alias
UMLS CUI-1
C3251812
ischemic stroke within the last year or any previous hemorrhagic stroke
Description

ischemic stroke within the last year or any previous hemorrhagic stroke

Data type

boolean

Alias
UMLS CUI-1
C0038454
tumor
Description

tumor

Data type

boolean

Alias
UMLS CUI-1
C0006826
cerebral arteriovenous malformation
Description

cerebral arteriovenous malformation

Data type

boolean

Alias
UMLS CUI-1
C0003857
intracranial aneurysm
Description

intracranial aneurysm

Data type

boolean

Alias
UMLS CUI-1
C0007766
recent (<1 month) trauma
Description

recent (<1 month) trauma

Data type

boolean

Alias
UMLS CUI-1
C3263723
major surgery (including bypass surgery)
Description

major surgery (including bypass surgery)

Data type

boolean

Alias
UMLS CUI-1
C0679637
currently receiving warfarin
Description

currently receiving warfarin

Data type

boolean

Alias
UMLS CUI-1
C0043031
active bleeding
Description

active bleeding

Data type

boolean

Alias
UMLS CUI-1
C0019080

Similar models

Eligibility Criteria

  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
Gender
Item
Male or non-pregnant female
boolean
C0079399 (UMLS CUI-1)
Pregnancy
Item
non-pregnant female
boolean
C0549206 (UMLS CUI-1)
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI-1)
PCI
Item
Patients undergoing percutaneous coronary intervention (PCI)
boolean
C1532338 (UMLS CUI-1)
Angina pectoris
Item
Stable angina (SA) patients
boolean
C0002962 (UMLS CUI-1)
Coronary angiography
Item
with diagnostic coronary angiography
boolean
C0085532 (UMLS CUI-1)
NSTEMI
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C3537184 (UMLS CUI-1)
Acute coronary syndrome
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
boolean
C1536220 (UMLS CUI-1)
Informed consent
Item
Provide written informed consent
boolean
C0021430 (UMLS CUI-1)
Item Group
Exclusion Criteria
Thienopyridines
Item
Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
boolean
C2936588 (UMLS CUI-1)
Eptifibatide
Item
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0253563 (UMLS CUI-1)
Tirofiban
Item
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0247025 (UMLS CUI-1)
Abciximab
Item
Abciximab usage within 7 days preceding randomization
boolean
C0288672 (UMLS CUI-1)
Thrombolytic Therapy
Item
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
boolean
C0040044 (UMLS CUI-1)
Bleeding risk
Item
Increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Stroke
Item
ischemic stroke within the last year or any previous hemorrhagic stroke
boolean
C0038454 (UMLS CUI-1)
Tumor
Item
tumor
boolean
C0006826 (UMLS CUI-1)
Cerebral arteriovenous malformation
Item
cerebral arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
intracranial aneurysm
Item
intracranial aneurysm
boolean
C0007766 (UMLS CUI-1)
Trauma
Item
recent (<1 month) trauma
boolean
C3263723 (UMLS CUI-1)
Major surgery
Item
major surgery (including bypass surgery)
boolean
C0679637 (UMLS CUI-1)
Warfarin
Item
currently receiving warfarin
boolean
C0043031 (UMLS CUI-1)
Hemorrhage
Item
active bleeding
boolean
C0019080 (UMLS CUI-1)